RxSight 

$5.57
22
+$0.32+6.1% Thursday 20:00
-$0.11-1.92%Thursday 23:46After hours

Statistics

Day High
5.6
Day Low
5.57
52W High
13.22
52W Low
4.48
Volume
104,494
Avg. Volume
-
Mkt Cap
230.58M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.38
-0.3
-0.23
-0.15
Expected EPS
-0.350489
Actual EPS
N/A

Financials

-28.96%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
134.48MRevenue
-38.94MNet Income

Analyst Ratings

9.08Average Price Target
The highest estimate is 11.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
17%
Hold
67%
Sell
17%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RXST. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
Show more...
CEO
Dr. Ronald M. Kurtz M.D.
Employees
461
Country
United States
ISIN
US78349D1072

Listings

0 Comments

Share your thoughts

FAQ

What is RxSight stock price today?
The current price of RXST is $5.57 USD — it has increased by +6.1% in the past 24 hours. Watch RxSight stock price performance more closely on the chart.
What is RxSight stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange RxSight stocks are traded under the ticker RXST.
Is RxSight stock price growing?
RXST stock has risen by +12.53% compared to the previous week, the month change is a +21.35% rise, over the last year RxSight has showed a -24.53% decrease.
What is RxSight market cap?
Today RxSight has the market capitalization of 230.58M
When is the next RxSight earnings date?
RxSight is going to release the next earnings report on August 05, 2026.
What were RxSight earnings last quarter?
RXST earnings for the last quarter are -0.38 USD per share, whereas the estimation was -0.3 USD resulting in a -27.14% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is RxSight revenue for the last year?
RxSight revenue for the last year amounts to 134.48M USD.
What is RxSight net income for the last year?
RXST net income for the last year is -38.94M USD.
How many employees does RxSight have?
As of July 17, 2026, the company has 461 employees.
In which sector is RxSight located?
RxSight operates in the Health & Wellness sector.
When did RxSight complete a stock split?
The last stock split for RxSight was on September 21, 2006 with a ratio of 9:1.
Where is RxSight headquartered?
RxSight is headquartered in Aliso Viejo, United States.